Literature DB >> 16712948

The relationship between immunosuppressive activity and immunoregulatory cytokines in seminal plasma: influence of sperm autoimmunity and seminal leukocytes.

Robert Ochsenkühn1, Anne E O'Connor, Jonathan J Hirst, H W Gordon Baker, David M de Kretser, Mark P Hedger.   

Abstract

While the contributions of prostasomes, polyamines and prostaglandins to the immunosuppressive activity (ISA) of human seminal plasma have been well-characterised, the contribution of immunoregulatory cytokines found in seminal plasma has received relatively little attention. Semen samples were collected from adult men displaying normospermic parameters, sperm antibodies or substantially elevated seminal leukocytes. Samples were processed through ultracentrifugation and dialysis (<3500Da) to remove prostasomes, polyamines and prostaglandins, and then assayed for ISA by an in vitro T lymphocyte inhibition assay, as well as by specific immunoassays for transforming growth factor beta(1) (TGFbeta(1)), interleukin-10 (IL-10), activin A and the activin-binding protein, follistatin. Seminal plasma from all groups retained substantial ISA following processing. Compared with normospermic men, this 'large' molecular weight ISA fraction was significantly increased in a subset of men with sperm antibodies, but was not altered in the group with elevated leukocytes. There was no relationship between ISA and any cytokine examined, and only TGFbeta(1) was present at levels sufficient to contribute to ISA. Inhibition with a TGFbeta-specific antibody reduced ISA in seminal plasma by approximately 50%. Across all patients, TGFbeta(1) levels were positively correlated with sperm numbers in the ejaculate and with activin A, but not with follistatin or IL-10. Activin A and IL-10 also displayed a positive relationship, and elevated leukocytes was associated with a significant elevation of IL-10 and activin A, but not TGFbeta(1). It is concluded that 'large' molecular weight molecules, the most important of which appears to be TGFbeta(1), make a significant contribution to immunosuppression by human seminal plasma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712948     DOI: 10.1016/j.jri.2006.01.002

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  7 in total

1.  Total urokinase-type plasminogen activator (uPA) levels in seminal plasma are associated with positive assisted reproductive technology outcomes.

Authors:  Juan Carlos Martinez-Soto; José Landeras; Marta Mollá; Irene Mondejar; María Nicolás; Laura Fernández-Olmedilla; Martina Trabalón; Pilar Coy; Joaquín Gadea
Journal:  J Assist Reprod Genet       Date:  2018-03-23       Impact factor: 3.412

Review 2.  Antisperm antibodies and conception.

Authors:  L W Chamley; G N Clarke
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

Review 3.  Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone.

Authors:  Kadri Haller-Kikkatalo; Andres Salumets; Raivo Uibo
Journal:  Clin Dev Immunol       Date:  2011-10-05

4.  Age-related immune-modulating properties of seminal fluid that control the severity of asthma are gender specific.

Authors:  Yuichi Niikura; Takashi Ishii; Jurika Murakami; Tomoya Narita; Yoko Fujita; Hiroaki Negishi; Yuji Taketani; Naomi Yamashita
Journal:  Aging (Albany NY)       Date:  2019-01-24       Impact factor: 5.682

5.  Manifestations of immune tolerance in the human female reproductive tract.

Authors:  Gary F Clark; Danny J Schust
Journal:  Front Immunol       Date:  2013-02-13       Impact factor: 7.561

6.  Coitus-Free Sexual Transmission of Zika Virus in a Mouse Model.

Authors:  Chad S Clancy; Arnaud J Van Wettere; John D Morrey; Justin G Julander
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

Review 7.  Coronavirus: A possible cause of reduced male fertility.

Authors:  Chuan Huang; Xiren Ji; Wenjun Zhou; Zhenghui Huang; Xiangjie Peng; Liqing Fan; Ge Lin; Wenbing Zhu
Journal:  Andrology       Date:  2020-10-11       Impact factor: 4.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.